NasdaqGM - Delayed Quote USD
KalVista Pharmaceuticals, Inc. (KALV)
11.34
-0.30
(-2.58%)
At close: May 14 at 4:00:01 PM EDT
10.82
-0.52
(-4.59%)
After hours: May 14 at 6:17:29 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 4 | 9 | 9 |
| Avg. Estimate | -0.83 | -0.95 | -3.56 | -2.96 |
| Low Estimate | -0.95 | -1.18 | -3.82 | -3.75 |
| High Estimate | -0.73 | -0.72 | -3.34 | -2.41 |
| Year Ago EPS | -1.07 | -0.87 | -3.44 | -3.56 |
Revenue Estimate
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 10 | 4 | 10 | 10 |
| Avg. Estimate | -- | 2M | -- | 30.82M |
| Low Estimate | -- | -- | -- | 15.76M |
| High Estimate | -- | 3.7M | -- | 55.4M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 4/30/2024 | 7/31/2024 | 10/31/2024 | 1/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.72 | -0.94 | -0.91 | -0.87 |
| EPS Actual | -1.07 | -0.87 | -0.91 | -0.92 |
| Difference | -0.35 | 0.07 | -0 | -0.05 |
| Surprise % | -48.27% | 7.94% | -0.22% | -6.02% |
EPS Trend
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.83 | -0.95 | -3.56 | -2.96 |
| 7 Days Ago | -0.83 | -0.95 | -3.56 | -2.96 |
| 30 Days Ago | -0.91 | -0.94 | -3.34 | -2.52 |
| 60 Days Ago | -0.91 | -0.94 | -3.62 | -2.9 |
| 90 Days Ago | -0.92 | -0.85 | -3.64 | -2.78 |
EPS Revisions
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 7 | -- | 4 | 4 |
| Up Last 30 Days | 7 | 2 | 4 | 4 |
| Down Last 7 Days | 1 | 1 | 4 | 4 |
| Down Last 30 Days | 1 | 1 | 4 | 4 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| KALV | 22.31% | -9.20% | -3.49% | 16.82% |
| S&P 500 | 13.20% | 2.98% | 8.01% | 13.77% |
Upgrades & Downgrades
| Reiterates | Needham: Buy to Buy | 4/8/2025 |
| Reiterates | Needham: Buy to Buy | 3/26/2025 |
| Reiterates | Citizens Capital Markets: Market Outperform to Market Outperform | 3/26/2025 |
| Maintains | Jones Trading: Buy to Buy | 3/26/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/14/2025 |
| Reiterates | Needham: Buy to Buy | 3/13/2025 |
Related Tickers
PHVS Pharvaris N.V.
16.07
-0.25%
URGN UroGen Pharma Ltd.
9.87
-2.66%
TARS Tarsus Pharmaceuticals, Inc.
42.90
+3.47%
ATXS Astria Therapeutics, Inc.
3.9700
+1.79%
ABEO Abeona Therapeutics Inc.
5.39
-4.26%
IDYA IDEAYA Biosciences, Inc.
17.10
-2.01%
TRML Tourmaline Bio, Inc.
15.50
-0.26%
EWTX Edgewise Therapeutics, Inc.
14.55
-2.28%
CRNX Crinetics Pharmaceuticals, Inc.
31.29
+1.10%
KURA Kura Oncology, Inc.
5.73
-1.21%